Detection of inherited metabolic disorders via tandem mass spectrometry in Thai infants
Related Experiment Video
Updated: Oct 7, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
P Wasant1, E W Naylor, S Liammongkolkul
1Department of Pediatrics, Siriraj Hospital Faculty of Medicine Mahidol University, Bangkok, Thailand.
Insights
This study highlights the prevalence of Inborn Errors of Metabolism (IEM) in Thai pediatric patients. Tandem mass spectrometry identified numerous metabolic disorders, emphasizing the need for advanced diagnostic tools.
Area of Science:
- Medical Genetics
- Pediatrics
- Biochemistry
Background:
- Inborn Errors of Metabolism (IEM) are a significant concern in pediatric populations.
- Previous estimations suggested 2-4% of pediatric admissions in Thailand had suspected IEM, often diagnosed clinically due to limited facilities.
Observation:
- A collaborative study utilized tandem mass spectrometry (MS/MS) for IEM diagnosis in high-risk infants and children.
- 146 samples were analyzed between July 1993 and March 1998.
Findings:
- The study detected a high prevalence of metabolic disorders, with 11.2% of tested individuals diagnosed with IEM.
- Specific disorders identified include phenylketonuria, organic acidemia, maple syrup urine disease, and G6PD deficiency.
Implications:
- The findings underscore the substantial burden of IEM in Thailand and the limitations of clinical diagnosis alone.
- Implementing advanced diagnostic technologies like MS/MS is crucial for accurate and timely identification of IEM in pediatric patients.
- Early diagnosis and intervention can significantly improve outcomes for children with metabolic disorders.
Abstract:
From a retrospective study in Medical Genetics Unit, Department of Pediatrics, Siriraj Hospital Faculty of Medicine, Mahidol University in Bangkok (1983-1988), the estimated pediatric patients with clinically suspected IEM are approximately 2-4% of total annual pediatrics admission of 5,000 or more. This is, a low estimation since survey from all teaching hospitals in the country including the largest Children's Hospital in Bangkok indicated the presence of numerous IEM. However, most IEM were clinically diagnosed with limited laboratory facilities. We started a collaboration with Magee Womens Hospital of Pittsburgh and NeoGen Screening, USA; using tandem mass spectrometry to diagnose high risk infants and children for IEM from July 1993 to March 1998. Of total 146 samples sent, we detected numerous metabolic disorders (11.2%) eg phenylketonuria, organic acidemia, maple syrup urine disease, isovaleric acidemia, methylmalonic acidemia, albinism, translocase/carnitine palmitoyltransferase type II, G6PD deficiency and lysinuric protein intolerance.
Related Concept Videos
Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
Tandem Mass Spectrometry
MALDI-TOF Mass Spectrometry
Rapid Identification of Pathogens

